news Scmp World 2026-10-26

US investment curbs could impact Chinese biotech sector expansion

New US outbound investment restrictions may complicate deal structures for Chinese biotech firms, even as drug licensing agreements remain currently unaffected.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10